175 related articles for article (PubMed ID: 5533298)
1. Circadian variation of glucose, insulin and free fatty acids during the long-term use of oral hypoglycaemic agents in diabetes mellitus with special reference to glibenclamide.
Hadden DR; Bhatia SK; Rigas A; Weaver JA; Montgomery DA
Postgrad Med J; 1970 Dec; ():Suppl:53-7. PubMed ID: 5533298
[No Abstract] [Full Text] [Related]
2. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
D'Onofrio F; Pempinello R; Romis L
Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
[No Abstract] [Full Text] [Related]
3. A comparison of glibenclamide with chlorpropamide in newly diagnoeed maturity-onset diabetes.
Gurling KJ
Postgrad Med J; 1970 Dec; ():Suppl:66-9. PubMed ID: 5533301
[No Abstract] [Full Text] [Related]
4. Diurnal blood sugar levels and clinical experience during glibenclamide therapy.
O'Sullivan DJ
Postgrad Med J; 1970 Dec; ():Suppl:46-9. PubMed ID: 5533296
[No Abstract] [Full Text] [Related]
5. Glibenclamide in the management of diabetes mellitus. I.
Devlin JG; Manning K; Harty J
J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
[No Abstract] [Full Text] [Related]
6. Comparison of glibenclamide with other oral hypoglycaemic agents.
Wetherill JH; Tunbridge RE
Postgrad Med J; 1970 Dec; ():Suppl:88-91. PubMed ID: 5533304
[No Abstract] [Full Text] [Related]
7. Twenty-four-hour urinary glucose levels during tolbutamide and glibenclamide therapy.
Cohen H; Clyne JR
Postgrad Med J; 1970 Dec; ():Suppl:50-2. PubMed ID: 5533297
[No Abstract] [Full Text] [Related]
8. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
Iacono G; Ghionni A; Colucci M; Verde G; Caputo G
Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
[No Abstract] [Full Text] [Related]
9. [Our experience with Daonil. A new oral hypoglycemic agent].
Rodriguez-Miñon JL; Arrieta F; Herrera JL
Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
[No Abstract] [Full Text] [Related]
10. [Diabetes mellitus 60 years after the start of treatment with insulin].
Doorenbos H
Ned Tijdschr Geneeskd; 1984 Nov; 128(46):2188-91. PubMed ID: 6392899
[No Abstract] [Full Text] [Related]
11. Circadian variation of glucose, insulin, and free fatty acids during long-term use of oral hypoglycaemic agents in diabetes mellitus.
Rigas AN; Bittles AH; Hadden DR; Montgomery DA
Br Med J; 1968 Oct; 4(5622):25-8. PubMed ID: 5677210
[TBL] [Abstract][Full Text] [Related]
12. [The development of sulfonylurea late resistance].
Angeli I
Med Klin; 1970 Feb; 65(7):306-9. PubMed ID: 4996930
[No Abstract] [Full Text] [Related]
13. [Normal plasma free fatty acid (C 16 -C 18 ) values in diabetics after treatment with an oral hypoglycemizing agent].
Bertolini AM; Santagostino A
Minerva Med; 1972 Mar; 63(20):1145-9. PubMed ID: 5018858
[No Abstract] [Full Text] [Related]
14. Plasma insulin and metabolic study on diabetes treated with glibenclamide.
Anderson J; Coulson R; Grassick BD; Morris BA; Thomas WD; Tomlinson RW; Woodroffe F
Postgrad Med J; 1970 Dec; ():Suppl:36-41. PubMed ID: 5533294
[No Abstract] [Full Text] [Related]
15. Insulin and oral hypoglycemic agents.
Price MJ
Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
[No Abstract] [Full Text] [Related]
16. Selected topics in the management of diabetes mellitus in cats.
Nelson RW
J Feline Med Surg; 2000 Jun; 2(2):101-4. PubMed ID: 11716601
[No Abstract] [Full Text] [Related]
17. [On the clinical use of biguanides].
Haese E
Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
[No Abstract] [Full Text] [Related]
18. [Progress in the therapy of diabetes].
Raptis S; Rothenbuchner G; Pfeiffer EF
Wien Med Wochenschr; 1971 Apr; 121(14):261-9. PubMed ID: 5559791
[No Abstract] [Full Text] [Related]
19. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.
Anan F; Masaki T; Fukunaga N; Teshima Y; Iwao T; Kaneda K; Umeno Y; Okada K; Wakasugi K; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Eur J Clin Invest; 2007 Sep; 37(9):709-14. PubMed ID: 17696960
[TBL] [Abstract][Full Text] [Related]
20. The role of technology in diabetes therapy.
Ginsberg BH
Diabetes Care; 1994 Jun; 17 Suppl 1():50-5. PubMed ID: 8088225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
